Rationale, design, and baseline characteristics of the Acetylcystein for Contrast-Induced nephropaThy (ACT) Trial: a pragmatic randomized controlled trial to evaluate the efficacy of acetylcysteine for the prevention of contrast-induced nephropathy

BACKGROUND: Aceltylcysteine has been evaluated in several small trials as a means of reducing the risk of contrast-induced nephropathy (CIN), however systematic reviews of these studies do not provide conclusive answers. Therefore, a large randomized controlled trial (RCT) is needed to provide a rel...

Descripción completa

Detalles Bibliográficos
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2706243/
https://www.ncbi.nlm.nih.gov/pubmed/19497091
http://dx.doi.org/10.1186/1745-6215-10-38

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2706243/
https://www.ncbi.nlm.nih.gov/pubmed/19497091
http://dx.doi.org/10.1186/1745-6215-10-38

Ejemplares similares